All clinical research using germline genome editing banned in China
By 
Julia Robinson2024-07-19T10:27:00
New guidelines follow creation of first gene-edited babies three years ago by He Jiankui
China’s science and technology ministry has prohibited all clinical research involving germline genome editing, describing the approach as ‘irresponsible’.
Germline genome editing involves making edits to DNA in egg, sperm or early embryos to introduce changes that can be inherited by future generations.
The South China Morning Post reports that the new Ethical Guideline for Human Genome Editing Research reflects China’s latest effort to tighten regulations following the case of Chinese researcher, He Jiankui, who claimed to have created the world’s first gene-edited babies.